Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 18 | 2023 | 180 | 3.630 |
Why?
|
| Atrial Appendage | 5 | 2022 | 45 | 1.990 |
Why?
|
| Catheter Ablation | 12 | 2021 | 78 | 1.820 |
Why?
|
| Pacemaker, Artificial | 7 | 2023 | 48 | 1.310 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2022 | 81 | 0.990 |
Why?
|
| Pulmonary Veins | 5 | 2020 | 23 | 0.930 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 89 | 0.790 |
Why?
|
| Stroke | 4 | 2022 | 293 | 0.770 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2020 | 149 | 0.720 |
Why?
|
| Heart Transplantation | 1 | 2018 | 38 | 0.670 |
Why?
|
| Bundle of His | 4 | 2022 | 32 | 0.600 |
Why?
|
| Cryosurgery | 3 | 2020 | 20 | 0.570 |
Why?
|
| Defibrillators, Implantable | 3 | 2023 | 30 | 0.520 |
Why?
|
| Treatment Outcome | 13 | 2022 | 3478 | 0.500 |
Why?
|
| Heart Failure | 3 | 2020 | 202 | 0.450 |
Why?
|
| Intercostal Muscles | 1 | 2011 | 3 | 0.410 |
Why?
|
| Electric Injuries | 1 | 2011 | 3 | 0.410 |
Why?
|
| Spasm | 1 | 2011 | 7 | 0.410 |
Why?
|
| Humans | 35 | 2023 | 29337 | 0.410 |
Why?
|
| Transposition of Great Vessels | 2 | 2008 | 6 | 0.360 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 44 | 0.340 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 30 | 0.330 |
Why?
|
| Risk Factors | 8 | 2022 | 2443 | 0.300 |
Why?
|
| Heart Rate | 4 | 2020 | 142 | 0.290 |
Why?
|
| Male | 18 | 2023 | 15621 | 0.280 |
Why?
|
| Electric Countershock | 1 | 2005 | 29 | 0.270 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2021 | 104 | 0.260 |
Why?
|
| Thrombosis | 2 | 2018 | 59 | 0.260 |
Why?
|
| Registries | 3 | 2021 | 188 | 0.250 |
Why?
|
| Aged | 12 | 2021 | 9448 | 0.250 |
Why?
|
| Action Potentials | 3 | 2020 | 136 | 0.240 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 21 | 0.240 |
Why?
|
| Heart Ventricles | 2 | 2022 | 170 | 0.240 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2023 | 6 | 0.240 |
Why?
|
| Anticoagulants | 2 | 2018 | 100 | 0.220 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 33 | 0.220 |
Why?
|
| Electrocoagulation | 1 | 2022 | 16 | 0.220 |
Why?
|
| Atrial Flutter | 3 | 2011 | 20 | 0.210 |
Why?
|
| Retrospective Studies | 9 | 2023 | 3273 | 0.210 |
Why?
|
| Equipment Design | 2 | 2021 | 185 | 0.210 |
Why?
|
| Risk Assessment | 5 | 2020 | 679 | 0.210 |
Why?
|
| Bradycardia | 1 | 2021 | 28 | 0.200 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 3 | 0.200 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 33 | 0.190 |
Why?
|
| Time Factors | 6 | 2021 | 1616 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2020 | 17 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2020 | 7 | 0.190 |
Why?
|
| Radiation Dosage | 1 | 2020 | 31 | 0.190 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 24 | 0.190 |
Why?
|
| Ventricular Premature Complexes | 1 | 2019 | 4 | 0.180 |
Why?
|
| Heparin Antagonists | 1 | 2019 | 1 | 0.180 |
Why?
|
| Protamines | 1 | 2019 | 6 | 0.180 |
Why?
|
| Hemostasis | 1 | 2019 | 11 | 0.180 |
Why?
|
| Middle Aged | 12 | 2020 | 9823 | 0.180 |
Why?
|
| Heparin | 1 | 2019 | 26 | 0.180 |
Why?
|
| Female | 15 | 2023 | 16197 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2019 | 75 | 0.180 |
Why?
|
| Punctures | 1 | 2018 | 10 | 0.170 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 34 | 0.170 |
Why?
|
| Adult | 7 | 2021 | 8601 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2019 | 141 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 49 | 0.170 |
Why?
|
| Image Enhancement | 1 | 2018 | 57 | 0.170 |
Why?
|
| Bundle-Branch Block | 1 | 2018 | 16 | 0.170 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 46 | 0.170 |
Why?
|
| Ventricular Fibrillation | 2 | 2016 | 30 | 0.160 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 10 | 0.160 |
Why?
|
| Computer Security | 1 | 2018 | 8 | 0.160 |
Why?
|
| Contrast Media | 1 | 2018 | 125 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2018 | 73 | 0.160 |
Why?
|
| Policy Making | 1 | 2017 | 15 | 0.160 |
Why?
|
| Stroke Volume | 3 | 2023 | 56 | 0.160 |
Why?
|
| Azygos Vein | 1 | 2017 | 3 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2017 | 10 | 0.160 |
Why?
|
| Incidental Findings | 1 | 2017 | 16 | 0.160 |
Why?
|
| Recurrence | 4 | 2020 | 350 | 0.150 |
Why?
|
| Consensus | 1 | 2017 | 105 | 0.150 |
Why?
|
| Cardiology | 1 | 2017 | 73 | 0.150 |
Why?
|
| Exercise | 1 | 2020 | 468 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2016 | 44 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2017 | 190 | 0.140 |
Why?
|
| Electrocardiography | 3 | 2022 | 209 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 11 | 0.100 |
Why?
|
| Heart Atria | 1 | 2011 | 71 | 0.100 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2010 | 21 | 0.100 |
Why?
|
| Telemetry | 1 | 2010 | 11 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 20 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2021 | 227 | 0.090 |
Why?
|
| Coronary Occlusion | 1 | 2010 | 2 | 0.090 |
Why?
|
| Fluoroscopy | 2 | 2020 | 52 | 0.090 |
Why?
|
| Exercise Test | 2 | 2020 | 122 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 29 | 0.090 |
Why?
|
| Coronary Angiography | 2 | 2010 | 91 | 0.090 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 34 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2010 | 71 | 0.090 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 3 | 0.090 |
Why?
|
| Iliac Vein | 1 | 2008 | 4 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2008 | 51 | 0.080 |
Why?
|
| Pericardium | 1 | 2008 | 20 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2007 | 11 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2007 | 17 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4851 | 0.070 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 23 | 0.070 |
Why?
|
| Amiodarone | 1 | 2005 | 26 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 43 | 0.070 |
Why?
|
| Warfarin | 1 | 2005 | 37 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 1811 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 45 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2022 | 32 | 0.050 |
Why?
|
| United States | 2 | 2019 | 2333 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 12 | 0.050 |
Why?
|
| Temperature | 1 | 2021 | 76 | 0.050 |
Why?
|
| Swine | 1 | 2021 | 80 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 66 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 402 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 6 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 11 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2020 | 12 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 22 | 0.050 |
Why?
|
| Lasers | 1 | 2020 | 16 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 175 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 52 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 340 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 42 | 0.050 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 8 | 0.050 |
Why?
|
| Alcoholism | 1 | 2020 | 83 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2020 | 159 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2020 | 394 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 123 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 97 | 0.040 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2018 | 8 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 389 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 266 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 756 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 843 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 9 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 787 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 24 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 291 | 0.040 |
Why?
|
| Myocardial Infarction | 2 | 2010 | 172 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 788 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 932 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 1932 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 4552 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 553 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 59 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 3 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 58 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 521 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 335 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 317 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 865 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 2279 | 0.010 |
Why?
|
| Length of Stay | 1 | 2005 | 317 | 0.010 |
Why?
|